These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 31249236

  • 41. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS.
    J Med Case Rep; 2020 Jan 13; 14(1):11. PubMed ID: 31928535
    [Abstract] [Full Text] [Related]

  • 42. Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura.
    Noris M, Remuzzi G.
    Semin Nephrol; 2010 Jul 13; 30(4):395-408. PubMed ID: 20807612
    [Abstract] [Full Text] [Related]

  • 43. Upshaw-Schulman Syndrome With c.2728C>T Mutation in ADAMTS13 Gene.
    Resham S, Fadoo Z, Moiz B.
    J Pediatr Hematol Oncol; 2019 Jan 13; 41(1):e60-e62. PubMed ID: 29771863
    [Abstract] [Full Text] [Related]

  • 44. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG, Kirsztajn GM.
    J Bras Nefrol; 2010 Jan 13; 32(3):303-15. PubMed ID: 21103695
    [Abstract] [Full Text] [Related]

  • 45. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.
    Clin Exp Nephrol; 2019 Jan 13; 23(1):112-121. PubMed ID: 30039480
    [Abstract] [Full Text] [Related]

  • 46. Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.
    Rubio-Haro R, Quesada-Carrascosa M, Hernández-Laforet J, Ferrer Gómez C, De Andrés J.
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Mar 13; 69(3):179-182. PubMed ID: 35283062
    [Abstract] [Full Text] [Related]

  • 47. Diagnosis of atypical hemolytic uremic syndrome and response to eculizumab therapy.
    Nguyen MH, Mathew JJ, Denunzio TM, Carmichael MG.
    Hawaii J Med Public Health; 2014 Sep 13; 73(9 Suppl 1):22-4. PubMed ID: 25285252
    [Abstract] [Full Text] [Related]

  • 48. Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome.
    Azoulay E, Knoebl P, Garnacho-Montero J, Rusinova K, Galstian G, Eggimann P, Abroug F, Benoit D, von Bergwelt-Baildon M, Wendon J, Scully M.
    Chest; 2017 Aug 13; 152(2):424-434. PubMed ID: 28442312
    [Abstract] [Full Text] [Related]

  • 49. Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007-2012.
    Åkesson A, Blom AM, Klintman J, Zetterberg E.
    Nephrology (Carlton); 2017 Jul 13; 22(7):555-561. PubMed ID: 27175932
    [Abstract] [Full Text] [Related]

  • 50. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
    Wei X, Li J, Zhan X, Tu L, Huang H, Wang Y.
    J Med Case Rep; 2022 Mar 04; 16(1):101. PubMed ID: 35241161
    [Abstract] [Full Text] [Related]

  • 51. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R.
    Br J Haematol; 2013 Nov 04; 163(4):514-9. PubMed ID: 24111495
    [Abstract] [Full Text] [Related]

  • 52. Thrombotic microangiopathies.
    Rosove MH.
    Semin Arthritis Rheum; 2014 Jun 04; 43(6):797-805. PubMed ID: 24360024
    [Abstract] [Full Text] [Related]

  • 53. [CME: Diagnostic Approach and Management of Thrombotic Microangiopathy].
    Sutter T, Fehr T, Venzin R.
    Praxis (Bern 1994); 2022 Jun 04; 111(14):771-777. PubMed ID: 36285415
    [Abstract] [Full Text] [Related]

  • 54. [TTP and aHUS: new insights].
    Miyakawa Y.
    Rinsho Ketsueki; 2017 Jun 04; 58(5):530-536. PubMed ID: 28592771
    [Abstract] [Full Text] [Related]

  • 55. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
    Cataland SR, Holers VM, Geyer S, Yang S, Wu HM.
    Blood; 2014 Jun 12; 123(24):3733-8. PubMed ID: 24695849
    [Abstract] [Full Text] [Related]

  • 56. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.
    Yoshida Y, Miyata T, Matsumoto M, Shirotani-Ikejima H, Uchida Y, Ohyama Y, Kokubo T, Fujimura Y.
    PLoS One; 2015 Jun 12; 10(5):e0124655. PubMed ID: 25951460
    [Abstract] [Full Text] [Related]

  • 57. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
    Farkas P, Csuka D, Mikes B, Sinkovits G, Réti M, Németh E, Rácz K, Madách K, Gergely M, Demeter J, Prohászka Z.
    Immunobiology; 2017 Feb 12; 222(2):119-127. PubMed ID: 27771173
    [Abstract] [Full Text] [Related]

  • 58. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr 12; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 59. New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination.
    Ma Q, Xu G.
    J Med Virol; 2023 Jul 12; 95(7):e28946. PubMed ID: 37436788
    [Abstract] [Full Text] [Related]

  • 60. Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure-A Rare Presentation: Diagnosis Supported by Skin Biopsy.
    Kichloo A, Chugh SS, Gupta S, Pandav J, Chander P.
    J Investig Med High Impact Case Rep; 2019 Jul 12; 7():2324709619842905. PubMed ID: 31010328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.